Skip to main content
TipRanks
Go Ultimate75% OFF

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Financial Statements

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Financial Overview

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's market cap is currently ¥17.77B. The company's EPS TTM is ¥0.85; its P/E ratio is 39.93; Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.38B¥ 980.45M¥ 716.91M¥ 533.88M¥ 354.56M
Gross Profit¥ 1.05B¥ 761.52M¥ 506.03M¥ 391.75M¥ 247.44M
Operating Income¥ 278.60M¥ 164.37M¥ -270.29M¥ -530.44M¥ -505.82M
EBITDA¥ 419.49M¥ 303.80M¥ -97.87M¥ -430.50M¥ -378.12M
Net Income¥ 173.20M¥ 33.54M¥ -382.95M¥ -602.16M¥ -545.58M
Balance Sheet
Cash & Short-Term Investments¥ 1.56B¥ 381.18M¥ 408.09M¥ 611.27M¥ 566.45M
Total Assets¥ 3.72B¥ 2.42B¥ 2.45B¥ 2.80B¥ 2.30B
Total Debt¥ 584.09M¥ 570.28M¥ 544.11M¥ 415.28M¥ 89.80M
Net Debt¥ -978.92M¥ 189.09M¥ 144.51M¥ -187.79M¥ 71.91M
Total Liabilities¥ 1.54B¥ 1.58B¥ 1.66B¥ 1.65B¥ 1.05B
Stockholders' Equity¥ 2.17B¥ 834.06M¥ 785.89M¥ 1.15B¥ 1.25B
Cash Flow
Free Cash Flow¥ 282.43M¥ 174.12M¥ -203.26M¥ -543.94M¥ -564.45M
Operating Cash Flow¥ 370.25M¥ 211.25M¥ -76.65M¥ -303.27M¥ -365.78M
Investing Cash Flow¥ -184.86M¥ -137.12M¥ -100.28M¥ -153.74M¥ -84.13M
Financing Cash Flow¥ 979.86M¥ -92.03M¥ -37.82M¥ 587.20M¥ 219.44M

Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Earnings and Revenue History

-800M0800M1.6B-240 %-120 %0 %120 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Liabilities to Assets

01.5B3B4.5B30 %45 %60 %75 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow

-500M-250M0250M500M750M1B1.3B202020212022202320242025OperatingInvestingFinancing

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Forecast EPS vs Actual EPS

0.10.20.20.30.30.40.4Q2 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss